Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Clinical and Applied Thrombosis/Hemostasis
Year: 2010  |  Volume: 16  |  Issue: 3  |  Page No.: 288 - 293

Human Platelet Aggregation and Degranulation Is Induced In Vitro by L-Thyroxine, but Not by 3,5,3'-Triiodo-L-Thyronine or Diiodothyropropionic Acid (DITPA)

S. S Mousa, F. B Davis, P. J Davis and S. A. Mousa    

Abstract:

The endogenous thyroid hormones L-thyroxine (T4) and 3,5,3'-triiodo-L-thyronine (T3) induce angiogenesis via an endothelial cell iodothyronine receptor on integrin Vβ3. This receptor also exists on platelets. Diiodothyropropionic acid (DITPA) and GC-1, a noniodinated thyroid hormone analog, also induce angiogenesis. Here we examined the effects of iodothyronines (L-T4 vs L-T3) and analogs DITPA and GC-1 on human platelet function. Subthreshold aggregation of platelets obtained from healthy human donors was induced with collagen. Platelet activation (proaggregation) and adenosine triphosphate (ATP) secretion (degranulation) induced by L-T 4, L-T4-agarose, L-T3, DITPA, or GC-1 were determined simultaneously. Platelet aggregation and ATP secretion induced by a subthreshold level of collagen were enhanced 3-fold by either L-T4 or L-T 4-agarose (0.01 µmol/L) as compared to control, whereas, L-T 3, DITPA, or GC-1 had no effect under the same conditions. The platelet proaggregatory and degranulation effects of L-T4 were blocked by the vβ3 antagonist XT199 (0.1 µmol/ L) and by tetraiodothyroacetic acid (tetrac; 0.1 µmol/L). Tetrac inhibits binding of thyroid hormone analogs to the receptor on vβ3 and lacks thyromimetic activity at this site; thus, the proaggregatory action of L-T4 likely involves the cell surface receptor on integrin vβ3. The thyroid hormone receptor (TR) on human platelets but not endothelial cells distinguishes among iodothyronines, reflecting quantitative differences in integrin sites on endothelial cells and platelets or qualitative differences in the phospholipids/protein microenvironment of endothelial and platelet membranes that can affect integrin function. Additional studies in different populations with larger sample sizes are warranted to determine the impact of the current findings on clinical interventions.

View Fulltext    |   Related Articles   |   Back
 
 
   
 
 
 
  Related Articles

No Article Found
 
 
 
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility